Fibrates are used in accessory therapy in many forms of hypercholesterolemia, usually in combination with statins [REF].
Although less effective in lowering LDL levels, the ability of fibrates to increase HDL and lower triglyceride levels seems to reduce insulin resistance when the dyslipidemia is associated with other features of the metabolic syndrome (hypertension and diabetes mellitus type 2) [REF].